View in EDS

Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.

Saved in:
Bibliographic Details
Title: Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.
Authors: Prueksapraopong C; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA., Fernandes A; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA., Campo Fernandez B; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA., Roy S; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA., Hollis RP; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA., Habtemariam B; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA., Pellin D; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Ceoldo G; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Lin TY; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Dang TT; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Cornetta K; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN., Romero Z; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA., Blazar BR; Division of Pediatric Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN., Shah AJ; Division of Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Stanford School of Medicine, Palo Alto, CA., Moore TB; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA., Sehl M; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA., Schiller GJ; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA., Kohn DB; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, Los Angeles, CA.
Source: Blood advances [Blood Adv] 2026 Jul 28; Vol. 10 (14), pp. 4991-5002.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42008008
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Prueksapraopong+C%22">Prueksapraopong C</searchLink>; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Fernandes+A%22">Fernandes A</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Campo+Fernandez+B%22">Campo Fernandez B</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Roy+S%22">Roy S</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Hollis+RP%22">Hollis RP</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Habtemariam+B%22">Habtemariam B</searchLink>; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Pellin+D%22">Pellin D</searchLink>; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ceoldo+G%22">Ceoldo G</searchLink>; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lin+TY%22">Lin TY</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Dang+TT%22">Dang TT</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Cornetta+K%22">Cornetta K</searchLink>; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Romero+Z%22">Romero Z</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Blazar+BR%22">Blazar BR</searchLink>; Division of Pediatric Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.<br /><searchLink fieldCode="AU" term="%22Shah+AJ%22">Shah AJ</searchLink>; Division of Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine, Stanford School of Medicine, Palo Alto, CA.<br /><searchLink fieldCode="AU" term="%22Moore+TB%22">Moore TB</searchLink>; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Sehl+M%22">Sehl M</searchLink>; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Schiller+GJ%22">Schiller GJ</searchLink>; Department of Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Kohn+DB%22">Kohn DB</searchLink>; Department of Pediatrics, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA.; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, Los Angeles, CA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jul 28; Vol. 10 (14), pp. 4991-5002.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42008008
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2026019869
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4991
    Titles:
      – TitleFull: Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Prueksapraopong C
      – PersonEntity:
          Name:
            NameFull: Fernandes A
      – PersonEntity:
          Name:
            NameFull: Campo Fernandez B
      – PersonEntity:
          Name:
            NameFull: Roy S
      – PersonEntity:
          Name:
            NameFull: Hollis RP
      – PersonEntity:
          Name:
            NameFull: Habtemariam B
      – PersonEntity:
          Name:
            NameFull: Pellin D
      – PersonEntity:
          Name:
            NameFull: Ceoldo G
      – PersonEntity:
          Name:
            NameFull: Lin TY
      – PersonEntity:
          Name:
            NameFull: Dang TT
      – PersonEntity:
          Name:
            NameFull: Cornetta K
      – PersonEntity:
          Name:
            NameFull: Romero Z
      – PersonEntity:
          Name:
            NameFull: Blazar BR
      – PersonEntity:
          Name:
            NameFull: Shah AJ
      – PersonEntity:
          Name:
            NameFull: Moore TB
      – PersonEntity:
          Name:
            NameFull: Sehl M
      – PersonEntity:
          Name:
            NameFull: Schiller GJ
      – PersonEntity:
          Name:
            NameFull: Kohn DB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 07
              Text: 2026 Jul 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1